Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Duyster

Showing results (31-40 of 53) with videos related to

Pageof 6
Sort By:
Blood|August 29, 2000
Bcr-Abl kinase down-regulates cyclin-dependent kinase inhibitor p27 in human and murine cell linesT Jonuleit, H van der Kuip, C Miething, et al.
Oncogene|November 13, 2001
Expression of the oncogenic NPM-ALK chimeric protein in human lymphoid T-cells inhibits drug-induced, but not Fas-induced apoptosisC Greenland, C Touriol, G Chevillard, et al.
British Journal of Cancer|June 9, 2005
Capecitabine plus docetaxel every 3 weeks in first- and second-line metastatic oesophageal cancer: final results of a phase II trialS Lorenzen, J Duyster, C Lersch, et al.
Leukemia|March 13, 2015
F604S exchange in FIP1L1-PDGFRA enhances FIP1L1-PDGFRA protein stability via SHP-2 and SRC: a novel mode of kinase inhibitor resistanceS P Gorantla, K Zirlik, A Reiter, et al.
Leukemia|March 3, 2007
The anticancer drug imatinib induces cellular autophagyA Ertmer, V Huber, S Gilch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2000
The tyrosine kinase inhibitor CGP 57148 (ST1 571) induces apoptosis in BCR-ABL-positive cells by down-regulating BCL-XC Oetzel, T Jonuleit, A Götz, et al.
Oncogene|October 26, 2010
The low frequency of clinical resistance to PDGFR inhibitors in myeloid neoplasms with abnormalities of PDGFRA might be related to the limited repertoire of possible PDGFRA kinase domain mutations in vitroN von Bubnoff, S P Gorantla, R A Engh, et al.
Journal of Stomatology, Oral and Maxillofacial Surgery|January 7, 2020
Combined androgen deprivation therapy in recurrent androgen-receptor-positive salivary duct carcinoma - a case report and review of the literatureP Poxleitner, K Shoumariyeh, D Steybe, et al.
Oncogene|November 3, 2009
Novel pathway in Bcr-Abl signal transduction involves Akt-independent, PLC-gamma1-driven activation of mTOR/p70S6-kinase pathwayB Markova, C Albers, F Breitenbuecher, et al.
Bone Marrow Transplantation|November 1, 2020
Prognostic factors for survival after allogeneic transplantation in acute lymphoblastic leukemiaC Greil, M Engelhardt, G Ihorst, et al.
Pageof 6

Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
Blood|August 29, 2000
Bcr-Abl kinase down-regulates cyclin-dependent kinase inhibitor p27 in human and murine cell linesT Jonuleit, H van der Kuip, C Miething, et al.
Oncogene|November 13, 2001
Expression of the oncogenic NPM-ALK chimeric protein in human lymphoid T-cells inhibits drug-induced, but not Fas-induced apoptosisC Greenland, C Touriol, G Chevillard, et al.
British Journal of Cancer|June 9, 2005
Capecitabine plus docetaxel every 3 weeks in first- and second-line metastatic oesophageal cancer: final results of a phase II trialS Lorenzen, J Duyster, C Lersch, et al.
Leukemia|March 13, 2015
F604S exchange in FIP1L1-PDGFRA enhances FIP1L1-PDGFRA protein stability via SHP-2 and SRC: a novel mode of kinase inhibitor resistanceS P Gorantla, K Zirlik, A Reiter, et al.
Leukemia|March 3, 2007
The anticancer drug imatinib induces cellular autophagyA Ertmer, V Huber, S Gilch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2000
The tyrosine kinase inhibitor CGP 57148 (ST1 571) induces apoptosis in BCR-ABL-positive cells by down-regulating BCL-XC Oetzel, T Jonuleit, A Götz, et al.
Oncogene|October 26, 2010
The low frequency of clinical resistance to PDGFR inhibitors in myeloid neoplasms with abnormalities of PDGFRA might be related to the limited repertoire of possible PDGFRA kinase domain mutations in vitroN von Bubnoff, S P Gorantla, R A Engh, et al.
Journal of Stomatology, Oral and Maxillofacial Surgery|January 7, 2020
Combined androgen deprivation therapy in recurrent androgen-receptor-positive salivary duct carcinoma - a case report and review of the literatureP Poxleitner, K Shoumariyeh, D Steybe, et al.
Oncogene|November 3, 2009
Novel pathway in Bcr-Abl signal transduction involves Akt-independent, PLC-gamma1-driven activation of mTOR/p70S6-kinase pathwayB Markova, C Albers, F Breitenbuecher, et al.
Bone Marrow Transplantation|November 1, 2020
Prognostic factors for survival after allogeneic transplantation in acute lymphoblastic leukemiaC Greil, M Engelhardt, G Ihorst, et al.
Pageof 6